Immunohistochemical analysis has revealed EGFR overexpression in 70% of thymomas and 53% of thymic carcinomas, with higher EGFR staining levels demonstrating a notable correlation with advanced stage III to IV tumors (44). Here, EGFR is linked to thymic carcinoma.